{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:02:39Z","timestamp":1794852159055,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["2U54NS065768-06"],"award-info":[{"award-number":["2U54NS065768-06"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ymgmr.2021.100803","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T20:36:56Z","timestamp":1633120616000},"page":"100803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Chitotriosidase as a biomarker for gangliosidoses"],"prefix":"10.1016","volume":"29","author":[{"given":"Sarah","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine R.","family":"Jarnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2021.100803_bb0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1432-1033.1997.00279.x","article-title":"Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase","volume":"244","author":"Renkema","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0015","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/intimm\/dxh328","article-title":"Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity","volume":"17","author":"van Eijk","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/BF02436762","article-title":"Elevated plasma chitotriosidase activity in various lysosomal storage disorders","volume":"18","author":"Guo","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/B:BOLI.0000043025.17721.fc","article-title":"The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update","volume":"27","author":"Michelakakis","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cca.2007.07.019","article-title":"Plasma chitotriosidase in lysosomal storage diseases","volume":"387","author":"Isman","year":"2008","journal-title":"Clin. Chim. Acta<font color=\"#000000\"\/>"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinbiochem.2013.10.024","article-title":"Blood spot versus plasma chitotriosidase: a systematic clinical comparison","volume":"47","author":"Elmonem","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12098-009-0249-0","article-title":"Plasma chitotriosidase activity in children with lysosomal storage disorders","volume":"77","author":"Sheth","year":"2010","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0045","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies","volume":"34","author":"Aerts","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1012492429191","article-title":"Clinically relevant therapeutic endpoints in type I Gaucher disease","volume":"24 Suppl 2","author":"Hollak","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0070","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2017.04.011","article-title":"Infantile gangliosidoses: mapping a timeline of clinical changes","volume":"121","author":"Jarnes Utz","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2015.06.002","article-title":"Neurocognition across the spectrum of mucopolysaccharidosis type I: age, severity, and treatment","volume":"116","author":"Shapiro","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2990.2002.00422.x","article-title":"Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis","volume":"28","author":"Jeyakumar","year":"2002","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymgme.2014.11.015","article-title":"Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses","volume":"114","author":"Utz","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity","volume":"37","author":"Archer","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2016.10.001","article-title":"Proteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional polyacrylamide gel electrophoresis","volume":"120","author":"Ou","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2018.09.005","article-title":"Metabolomics profiling reveals profound metabolic impairments in mice and patients with sandhoff disease","volume":"126","author":"Ou","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0105","series-title":"Chitotriosidase as a biomarker for central nervous system inflammation in the gangliosidosis diseases","author":"Whitley","year":"2019"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clinbiochem.2006.12.003","article-title":"Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease","volume":"40","author":"Wajner","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0115","article-title":"Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling","volume":"20","author":"Ou","year":"2019","journal-title":"Mol. Genet. Metabol. Rep."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0120","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/cge.13226","article-title":"SAAMP 2.0: analgorithm to predict genotype-phenotype correlation of lysosomal storage diseases","volume":"93","author":"Ou","year":"2018","journal-title":"Clin. Genet"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jpeds.2019.08.016","article-title":"The clinical and molecular spectrum of GM1 gangliosidosis","volume":"215","author":"Arash-Kaps","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bone.2014.01.005","article-title":"Determination of chitinases family during osteoclastogenesis","volume":"61","author":"Di Rosa","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0135","series-title":"in Biomarkers in Bone Disease","first-page":"301","author":"Rosa","year":"2017"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0140","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar3111","article-title":"Bone events and evolution of biologic markers in Gaucher disease before and during treatment","volume":"12","author":"Stirnemann","year":"2010","journal-title":"Arthritis Res. Therapy"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0145","article-title":"Accuracy of chitotriosidase activity and CCL18 concentration in assessing type I Gaucher disease severity. A systematic review with meta-analysis of individual participant data","author":"Raskovalova","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0150","doi-asserted-by":"crossref","first-page":"2682680","DOI":"10.1155\/2016\/2682680","article-title":"Immunomodulatory effects of chitotriosidase enzyme","volume":"2016","author":"Elmonem","year":"2016","journal-title":"Enzyme Res."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1559-0275-10-19","article-title":"Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis","volume":"10","author":"Varghese","year":"2013","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0160","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1572-0241.2006.00680.x","article-title":"Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution","volume":"101","author":"Malaguarnera","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0165","series-title":"Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation","first-page":"10954","volume":"97","author":"Wada","year":"2000"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0170","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2169\/internalmedicine.49.3113","article-title":"Evaluating the validity of serum neopterin and chitotriosidase levels in follow-up brucellosis patients","volume":"49","author":"Coskun","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/TCRM.S31752","article-title":"Efficacy of serum chitotriosidase activity in early treatment of patients with active tuberculosis and a negative sputum smear","volume":"8","author":"Tasci","year":"2012","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0180","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/01.ATV.0000089329.09061.07","article-title":"Serum chitotriosidase activity is increased in subjects with atherosclerosis disease","volume":"23","author":"Artieda","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgmr.2021.100803_bb0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1742-2094-8-144","article-title":"Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy","volume":"8","author":"Orchard","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ymgmr.2021.100803_bb0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12017-011-8147-9","article-title":"Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility","volume":"13","author":"Mattsson","year":"2011","journal-title":"Neuromol. Med."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921000975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:33Z","timestamp":1762001493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426921000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"alternative-id":["S2214426921000975"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100803","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chitotriosidase as a biomarker for gangliosidoses","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100803"}}